10 November – As the global efforts to achieve the ambitious HIV targets accelerate, the World Health Organization prepares to issue new recommendations for countries to address important gaps in HIV prevention and treatment services. On December 1, WHO will release a new update to recommend antiretrovirals as an emergency prevention following HIV exposure, and to prevent and manage common opportunistic infections that affect a large number of people living with HIV.
First PROMISE study results confirm WHO recommendations to treat pregnant women and reduce mother-to-child-transmission of HIV
17 November 2014 - The United States National Institute of Allergy and Infectious Diseases (NIAID) published interim results of the PROMISE (Promoting Maternal-Infant Survival Everywhere) study. The PROMISE study aims to determine how best to safely reduce the risk of HIV transmission from infected pregnant women to their babies during pregnancy and after delivery and assure the benefits of antiretroviral therapy (ART) for the health of the mother. Started in 2010, the study has enrolled more than 3500 HIV-infected pregnant or post-partum women in India, Malawi, South Africa, Tanzania, Uganda, Zambia and Zimbabwe.
15 October - WHO organized a small consultation of key experts on the topic of HIV pre-exposure prophylaxis (PrEP) adherence to discuss how to consider and measure PrEP adherence beyond the context of clinical trials. The consultation took place on 8 June 2014 in Miami, USA. The report captures the process of the consultation, key agreements and next action points, and the list of participants.
22 October 2014 - WHO issues an information note to urgently remind the Ministries of Health and National AIDS Control Programmes to retest all persons newly diagnosed as HIV positive at the time of ART initiation to rule out potential misdiagnosis. This follows some recently published literature and unpublished programme data on HIV status misclassification reporting on both false positive and false negative results. These reports have raised concerns that some individuals might be started on antiretroviral therapy inappropriately.
11.7 million At the end of 2013, 11.7 million people had access to antiretroviral therapy in low- and middle-income countries.Fact sheet on HIV/AIDS
35 millionAt the end of 2013, 35 million people were living with HIV.Online Q&A about HIV/AIDS
28 million Over 28 million people are eligible for antiretroviral therapy, under WHO 2013 consolidated ARV guidelines.10 facts on HIV
8 September 2014